| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/08/2011 | US7901666 Nanoparticles for protein drug delivery |
| 03/08/2011 | US7901453 Coated implantable medical device |
| 03/08/2011 | CA2422291C Targeted alpha particle therapy using actinium-225 conjugates |
| 03/03/2011 | WO2011003902A3 Multimodal visible polymer embolization material |
| 03/03/2011 | WO2010028216A8 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 03/03/2011 | US20110054237 Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets |
| 03/03/2011 | US20110052492 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 03/03/2011 | US20110052491 Gastrin releasing peptide compounds |
| 03/03/2011 | US20110052490 Endoscopic mucosal resectioning using purified inverse thermosensitive polymers |
| 03/03/2011 | US20110052489 Anti-CD19 Antibodies |
| 03/03/2011 | US20110052488 Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis |
| 03/03/2011 | DE202005021885U1 Hydroxyalkylstärke-Protein-Konjugate, durch reduktive Aminierung hergestellt A hydroxyalkyl starch protein conjugates prepared by reductive amination |
| 03/02/2011 | EP2289598A1 Method and apparatus for therapeutic treatment of the skin |
| 03/02/2011 | EP2289564A2 Derivatives of aniline as precursors for F18-labeling |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2288609A2 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods |
| 03/02/2011 | EP2288388A1 Achievement of high therapeutic index through molecular imaging guided targeted drug treatment |
| 03/02/2011 | EP1663320B1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 03/02/2011 | CN101168554B Method for preparing 18F-FLT |
| 03/01/2011 | US7897740 Secreted protein called 36P6D5 characteristic of tumors |
| 03/01/2011 | US7897722 Composition of bone formation with PHSRN-RGD containing oligopeptide |
| 03/01/2011 | US7896914 Coated implantable medical device |
| 02/24/2011 | WO2011022707A1 Vesicular formulations |
| 02/24/2011 | WO2011021390A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide |
| 02/24/2011 | WO2011021001A1 Peptidic conjugates comprising polyhistidine sequence and free cysteine and their uses in imaging |
| 02/24/2011 | WO2011020907A1 Radioiodination method |
| 02/24/2011 | WO2010120368A3 Stabilization of radiopharmaceutical compositions using ascorbic acid |
| 02/24/2011 | US20110046723 Coated implantable medical device |
| 02/24/2011 | US20110045516 Kits Pertaining to Analyte Determination |
| 02/24/2011 | US20110044899 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | US20110044897 Method of imaging localized infections |
| 02/24/2011 | US20110044896 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
| 02/24/2011 | US20110044895 Methods and compositions for reducing stemness in oncogenesis |
| 02/24/2011 | US20110044894 Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof |
| 02/23/2011 | EP2287201A2 RS7 antibodies |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2286795A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/23/2011 | EP2285778A1 Nicotinamide derivatives |
| 02/23/2011 | EP2285759A1 Radiolabelled mmp selective compounds |
| 02/23/2011 | EP1651957B1 Fluorescent magnetic nanoparticles and process of preparation |
| 02/23/2011 | CN101979398A Thymine compound and application thereof as molecular probe target material |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/22/2011 | US7893266 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers |
| 02/22/2011 | US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/22/2011 | US7893196 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 02/22/2011 | US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 02/22/2011 | US7892547 Methods and compositions for administering therapeutic and diagnostic agents |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/17/2011 | WO2011019020A1 Molecular probe for imaging of pancreatic islet and precursor thereof, and use of the molecular probe or the precursor |
| 02/17/2011 | WO2010142754A3 Pet imaging of fibrogenesis |
| 02/17/2011 | WO2010065902A3 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 02/17/2011 | US20110038796 Method of Nuclear Medical Photography Using Dual-Isotopes |
| 02/17/2011 | US20110038795 Targeted radiotherapy |
| 02/17/2011 | US20110038794 Method of radiolabelling carbon nanotubes, radiolabelled carbon nanotubes and applications thereof |
| 02/17/2011 | US20110038793 Microsphere comprising an organic lanthanide metal complex |
| 02/17/2011 | US20110038792 Induction of thyroid iodide-handling gene expression in human cancers |
| 02/17/2011 | US20110038791 Methods for inhibiting six1 and eya proteins |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/16/2011 | EP2283871A1 Imaging infection with compounds that bind to thymidine kinase |
| 02/16/2011 | EP2282982A1 Novel [f-18]-labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production |
| 02/16/2011 | EP2282981A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them |
| 02/16/2011 | EP2282782A1 Methods for radiolabelling macromolecules |
| 02/16/2011 | EP2282781A1 Methods for radiolabelling synthetic polymers |
| 02/16/2011 | CN101972478A 抗体治疗 Antibody therapy |
| 02/15/2011 | US7888459 reaction to achieve facile covalent cross-linking of proteins by lyophilizing protein or proteins with compounds containing two or more reducing sugars separated by a linker; colyophilization of a protein with a reducing sugar |
| 02/15/2011 | US7888330 Phosphoramidate derivatives of FAU |
| 02/15/2011 | US7888119 Tissue substitutes comprising stem cells and reduced ceria |
| 02/15/2011 | US7887846 Process for preparation of swellable and degradable microspheres |
| 02/15/2011 | US7887784 Potent and selective binding affinity for the norpeinephrine transporter (NET) protein found in peripheral and central nervous system tissues |
| 02/15/2011 | US7887783 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical |
| 02/15/2011 | US7887782 Centrifuging, precipitation, sterilization, filtration |
| 02/15/2011 | CA2456411C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/10/2011 | WO2011017583A1 Compositions containing jarid1b inhibitors and methods for treating cancer |
| 02/10/2011 | WO2011017456A2 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
| 02/10/2011 | WO2011016376A1 Isotopelabeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same |
| 02/10/2011 | WO2011015958A2 Oncology therapies employing radioactive seeds |
| 02/10/2011 | US20110033382 Imaging Agents |
| 02/10/2011 | US20110033381 Molecular probe for imaging of pancreatic islet and the precursor, and use of the same |
| 02/10/2011 | US20110033380 Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 02/10/2011 | US20110033379 Radio-labeled materials and methods of making and using the same |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | US20110033377 Assay to detect a gynecological condition |
| 02/10/2011 | US20110033376 Treatment of Melanoma |
| 02/09/2011 | EP2281580A2 Labeled gastrin releasing peptides (GRP) |
| 02/09/2011 | EP2280915A1 Novel ýf-18¨-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production |
| 02/09/2011 | EP2280735A2 Agents for detecting and imaging cell death |
| 02/09/2011 | EP2007340B1 Integrated pharmaceutical production, quality assurance, and safety system (iqs) |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN101970017A Imaging the central nervous system |
| 02/09/2011 | CN101970016A Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals |
| 02/09/2011 | CN101967149A Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of nitryl and preparation and application |
| 02/09/2011 | CN101967148A Novel pyrazolo[1,5-a]pyrimidines compound for labeling 18F instead of p-benzenesulfonyloxy and preparation and application |
| 02/09/2011 | CN101293864B Compound having affinity with brain A beta plaque, preparation method and application thereof |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |